References
Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–93.
Bevilacqua JL, Kattan MW, Fey JV, Cody HS 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25(24):3670–9.
Nakauchi C, Naoi Y, Shimazu K, et al. Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsy. Cancer Lett. 2014;353(1):52–8.
Okuno J, Miyake T, Sota Y, et al. Development of prediction model including microRNA expression for sentinel lymph node metastasis in ER-positive and HER2-negative breast cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08735-9.
Funding
Funding was provided by Japan Society for the Promotion of Science (Grant No. JP18K08569).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Shinzaburo Noguchi is an advisory for and has received honoraria and research funding not related to this study from Sysmex and holds joint patents not related to this study with Sysmex. No other authors have declared any conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Okuno, J., Miyake, T., Shimazu, K. et al. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2− Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy. Ann Surg Oncol 27 (Suppl 3), 810–811 (2020). https://doi.org/10.1245/s10434-020-08797-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08797-9